Biontech investor calendar
WebFinancial Calendar BioNTech - investors.biontech.de Web2 days ago · BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific …
Biontech investor calendar
Did you know?
Web1 day ago · The global mRNA Vaccines & Therapeutics market size was valued at USD 40960.0 million in 2024 and is expected to expand at a CAGR of -31.55% during the … WebMay 9, 2024 · At the beginning of April 2024, BioNTech published its second ESG report (Sustainability Report 2024), which can be found in the Investor Relations section of …
WebApr 11, 2024 · 13 analysts have issued twelve-month price targets for BioNTech's shares. Their BNTX share price forecasts range from $130.00 to $260.00. On average, they anticipate the company's share price to reach $178.50 in the next twelve months. This suggests a possible upside of 38.5% from the stock's current price. WebNov 13, 2024 · All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law. CONTACTS. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 [email protected]. Investor Relations Sylke Maas, PhD. +49 (0)6131 9084 1074 …
WebApr 29, 2024 · BioNTech Media Relations Jasmina Alatovic Senior Manager Global External Communications Tel: +49 (0)6131 9084 7640 or +49 (0)151 1978 1385 E-mail: [email protected] BioNTech Investor Relations WebNov 30, 2024 · BioNTech: Media Relations Jasmina Alatovic +49 6131 9084 1513 [email protected]. Investor Relations Sylke Maas, Ph.D. +49 6131 9084 1074 [email protected]. Ryvu Therapeutics: Investors Contact: John Fraunces LifeSci Advisors +1 917-355-2395 [email protected]. Media Contact: Natalia …
WebApr 10, 2024 · 0. 0. In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 and a low of $128.00. Below is a ...
WebJul 27, 2024 · AC Immune SA (NASDAQ: ACIU) has gained a multi-million investment from the principal backers of BioNTech SE (NASDAQ: BNTX) while acquiring a possible Parkinson's disease vaccine. iowa state university phd statWebMar 20, 2024 · BioNTech Investor Relations Michael Horowicz +1 617 955 7420 [email protected]. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 [email protected]. OncoC4 Investor Relations Martin Devenport open house printingWebMar 13, 2024 · 02.28.2024. Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older … iowa state university philosophyWebSep 18, 2024 · In other words, as many stocks worldwide were hitting 52-week low in mid-March, BioNTech investors were jubilant. Yet in a matter of weeks, the shares were down to the $40 level. open house promotional items with gumWebMay 9, 2024 · BioNTech's first-quarter sales and earnings more than tripled thanks to demand for the COVID-19 vaccine it developed with Pfizer , but the German biotech firm … iowa state university philosophy departmentWebFeb 4, 2024 · BioNTech’s largest shareholders are biotech investors Thomas and Andreas Struengmann, who hold about half of the company’s shares between them. ($1 = 0.8341 euros) Reporting by Ludwig Burger ... iowa state university phone directoryWebApr 6, 2024 · Earnings Summary. For their last quarter, BioNTech (BNTX) reported earnings of $9.46 per share, beating the Zacks Consensus Estimate of $8.04 per share. … iowa state university physics courses